LBRX: Chief medical officer Susan Kozauer received 200,000 shares

What happened The Form 4 filed Oct 13, 2026 reports that on Oct 9, 2026 Susan Kozauer, chief medical officer, received a grant/award of 200,000 shares as a derivative award at $0.00 per share, total value $0.

Key details

• Transaction date and price: Oct 9, 2026; grant/award (code A); price $0.00 per share; total $0.
• Shares owned after the transaction: not reported on the Form 4.
• Footnote: one fourth (1/4th) of the shares subject to the award vest on Sep 14, 2027; the remaining shares vest monthly on the last day of the month starting Sep 30, 2027, subject to continuous service (footnote F1).
• Filing date: Oct 13, 2026. (No transaction timeliness flag indicated in the provided data.)

Why it may matter

• This was a derivative grant/award, not a market purchase or sale; the shares vest over time per the footnote.
• A filing does not show why the insider traded or why the company acted.